Related Experiment Videos
Managing pulmonary embolism.
1Harvard University, Harvard Medical School, Boston.
Hospital Practice (Office Ed.)
|September 15, 1991
Summary
Effective strategies now exist to prevent disease development in at-risk patients. For those unaffected by prophylaxis, improved diagnostic and anticoagulation therapies, including thrombolysis, offer better outcomes.
Area of Science:
- Medical Science
- Clinical Medicine
Background:
- High morbidity and mortality rates associated with the disease persist.
- Existing prophylactic strategies are effective for many at-risk individuals.
Purpose of the Study:
- To review current effective strategies for disease prevention.
- To discuss optimal diagnostic and therapeutic approaches for patients not benefiting from prophylaxis.
Main Methods:
- Review of existing literature on disease prevention and treatment.
- Analysis of diagnostic strategies and anticoagulation therapies.
- Evaluation of thrombolysis as a treatment option.
Main Results:
- Effective disease prevention strategies are available for at-risk populations.
- Diagnostic and anticoagulation therapies (heparin, warfarin) have improved.
- Thrombolysis shows potential for improving patient outcomes.
Conclusions:
- While challenges remain, advancements in prevention and treatment offer improved patient management.
- Optimal diagnostic and therapeutic pathways are crucial for patients unresponsive to prophylaxis.